Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation-Reference-Cited by-同舟云学术

Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation

Published:2018-03-23 Issue:9 Volume:18 Page:2135-2147
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Zuckerman Warren A.¹^ORCID,Zeevi Adriana²,Mason Kristen L.³,Feingold Brian⁴,Bentlejewski Carol²,Addonizio Linda J.¹,Blume Elizabeth D.⁵,Canter Charles E.⁶,Dipchand Anne I.⁷,Hsu Daphne T.⁸,Shaddy Robert E.⁹,Mahle William T.¹⁰,Demetris Anthony J.²,Briscoe David M.¹¹,Mohanakumar Thalachallour¹²,Ahearn Joseph M.¹³,Iklé David N.³,Armstrong Brian D.³,Morrison Yvonne¹⁴,Diop Helena¹⁴,Odim Jonah¹⁴,Webber Steven A.¹⁵

Affiliation:

1. Division of Pediatric Cardiology; Columbia University Medical Center; New York NY USA

2. Department of Pathology; University of Pittsburgh Medical Center; Pittsburgh PA USA

3. Rho Inc., Federal Systems Division; Chapel Hill NC USA

4. Department of Pediatrics and Clinical and Translational Science; University of Pittsburgh School of Medicine; Pittsburgh PA USA

5. Department of Pediatric Cardiology; Boston Children's Hospital; Boston MA USA

6. Division of Pediatric Cardiology; Washington University School of Medicine; St. Louis; MO USA

7. Labatt Family Heart Center; Department of Paediatrics; Hospital for Sick Children; Toronto ON Canada

8. Division of Pediatric Cardiology; Children's Hospital at Montefiore; Bronx NY USA

9. Division of Pediatric Cardiology; Children's Hospital of Philadelphia; Philadelphia PA USA

10. Division of Pediatric Cardiology; Children's Healthcare of Atlanta; Atlanta GA USA

11. Transplant Research Program; Division of Pediatric Nephrology; Harvard Medical School; Boston MA USA

12. Norton Thoracic Institute; Saint Joseph Hospital and Medical Center; Phoenix AZ USA

13. Department of Medicine; Allegheny Health Network; Pittsburgh PA USA

14. Transplantation Branch; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda MD USA

15. Division of Pediatric Cardiology; Monroe Carrell Jr. Children's Hospital at Vanderbilt; Nashville TN USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14695/fullpdf

Reference31 articles.

1. Survival in allosensitized children after listing for cardiac transplantation;Feingold;J Heart Lung Transplant,2007

2. Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation;Feingold;J Heart Lung Transplant,2013

3. Allosensitization and outcomes in pediatric heart transplantation;Mahle;J Heart Lung Transplant,2011

4. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database;Rossano;J Thorac Cardiovasc Surg,2010

5. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation;Lavee;J Heart Lung Transplant,1991

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of a positive crossmatch on pediatric heart transplant outcomes;The Journal of Heart and Lung Transplantation;2024-06

2. Pediatric heart transplantation: Looking forward after five decades of learning;Pediatric Transplantation;2023-12-08

3. Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study;American Journal of Transplantation;2023-12

4. Selection and Interpretation of Molecular Diagnostics in Heart Transplantation;Circulation;2023-08-22

5. Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II;Frontiers in Immunology;2023-03-14